BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23579063)

  • 1. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression.
    Llorente-Izquierdo C; Mayoral R; Cucarella C; Grau C; Alvarez MS; Flores JM; García-Palencia P; Agra N; Castro-Sánchez L; Boscá L; Martín-Sanz P; Casado M
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():106-15. PubMed ID: 23579063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
    Calvisi DF; Thorgeirsson SS
    Toxicol Pathol; 2005; 33(1):181-4. PubMed ID: 15805070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis.
    Llorente Izquierdo C; Mayoral R; Flores JM; García-Palencia P; Cucarella C; Boscá L; Casado M; Martín-Sanz P
    Am J Pathol; 2011 Mar; 178(3):1361-73. PubMed ID: 21356386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM; Jensen MR; Thorgeirsson SS
    Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.
    Calvisi DF; Simile MM; Ladu S; Pellegrino R; De Murtas V; Pinna F; Tomasi ML; Frau M; Virdis P; De Miglio MR; Muroni MR; Pascale RM; Feo F
    Int J Cancer; 2007 Dec; 121(11):2410-20. PubMed ID: 17680562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
    Ohgaki H; Sanderson ND; Ton P; Thorgeirsson SS
    Cancer Lett; 1996 Aug; 106(1):43-9. PubMed ID: 8827045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
    Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
    Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
    J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
    Jakubczak JL; Chisari FV; Merlino G
    Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-stage model of chemically induced hepatocellular carcinoma in mouse.
    Luo M; Yang F; Huang SX; Kuang ZP; Luo XL; Li YD; Wu JN; Xie YA
    Oncol Res; 2013; 20(11):517-28. PubMed ID: 24063282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.